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Abstract—In this study event-related potentials (ERPs) were
used to investigate the effects of prenatal alcohol exposure on
response inhibition identified during task performance. ERPs
were recorded during a auditory Go/No Go task in two groups
of children with mean age of 12.8years (11years to 14.7years):
one diagnosed with fetal alcohol syndrome (FAS) or partial FAS
(FAS/PFAS; n = 12) and a control group of children of same
age whose mothers abstained from alcohol or drank minimally
during pregnancy (n = 11). The children were instructed to push
a button in response to the Go stimulus and not to press the
button when the No Go stimulus were heard.
Task performance accuracy did not differ between the two
groups, however differences were observed in the ERP compo-
nents: P2, N2, and P3. The P2 amplitude were larger for Go trials
in both groups. The FAS/PFAS group showed slower N2 response
to Go trials, suggesting a less efficient early classification of the
stimulus. P3 showed larger amplitudes to No-Go vs. Go in both
groups.
The study has provided new evidence for inhibition deficits in
FAS/PFAS subjects identified by ERPs.
I. INTRODUCTION
Mothers failing to abstaining from alcohol during pregnancy
will expose their child to alcohol, in which case the child is
said to have had prenatal exposure to alcohol (PEA). Fetal
Alcohol Syndrome (FAS), one of several disorders related to
PEA, was first described in 1973 as a set of facial anomalies
(short palpebral fissures, flat midface, thin upper lip, and a
flat or smooth philtrum), accompanied by prenatal and/or
postnatal growth retardation and cognitive/behavioral issues [1].
Children showing typical facial dysmorphic and abnormalities
in one of the other domains (growth or central nervous
system structure or function) is diagnosed with partial FAS
(PFAS) [2]. The term Fetal Alcohol Spectrum Disorder (FASD)
describes the continuum of adverse effects of alcohol on the
developing human, with FAS being in the severe end. Despite
the absence of some of the characteristic dysmorphic features,
the severity of the cognitive deficits associated with PFAS
can be comparable to those seen in FAS, therefore these two
groups are often combined for analyses related to cognitive
and executive function deficits [3].
It is has been suggested that deficits in response inhibition,
a key aspect of executive function that refers to the ability to
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selectively respond and attend to non-targets while inhibiting
responses to targets, may be related to PEA [3]. Event-related
Potentials (ERP), which is derived from Electroencephalog-
raphy (EEG) recordings, is a class of evoked potentials that
reflect task-specific changes in the electric activity in the brain.
ERPs can be particular useful for characterizing brain activity
in different experimental situations, since the ERP component
amplitude (µV) and latency (ms) vary with task demands and
stimuli.
The ERP components that are most likely to reflect sensory
and cognitive processes associated with task demands are the
P2-N2-P3 complex. In the auditory domain the function of
the ERP component P2, a positive wave typically occurring
in the interval 150ms to 250ms after stimulus onset, is quite
unknown, however it is though to play a role in stimulus
classification and in inhibition processes [4]. Typically evoked
at latency 200ms to 350ms is the second negative wave, N2,
also thought to be related to the cognitive process of stimulus
identification and distinction. Finally P3 (also known as P300),
the most investigated ERP component, is a positive voltage
deflection in the interval 250ms to 600ms generally thought
to reflect the level of attention and task demand [5].
Recently Burden et al. 2009 [3] have investigated effects of
FAS/PFAS on response inhibition in children by studying event-
related potentials (ERP) using a visual Go/No-Go paradigm. It
was found that there was a significant difference between the
FAS/PFAS group and the normal controls in: P2 latency, N2
amplitude, P3 amplitude, and late slow wave (LSW). Kaneko et
al. 1996 [6] found significant longer P300 latencies for patients
with FASD.
This study sets out to investigate the above mentioned ERP
components in patients with FASD in response to auditory
stimuli and compare the results with those found in the excellent
study by Burden et al. [3], in which a visual stimuli Go/No-Go
paradigm was used on a subset of the subjects available for the
present study. For the purpose of comparability the methods
used in this paper has been chosen to resemble the methods
used by Burden et al. as close as possible.
II. METHODS
A. Participants
The participants used in this study were recruited from the
Cape Coloured (mixed ancestry) community in Cape Town,
South Africa. A part of the South African population known
to have a very high prevalence of FAS/PFAS [7]. The subjects
were recruited from two groups: The older siblings of children
in the Cape Town Longitudinal Cohort Study [8]. Children
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selected based on a screening undertaken at an elementary
school in a nearby rural section of Cape Town, where there
is a very high incidence of alcohol abuse among local farm
workers [9]. The diagnosis of FAS/PFAS in the subjects were
made by one of three expert dysmorphologists (HEH, LKR,
NK; see [8]) based on the revised Institute of Medicine criteria
[2]. Only children who met the diagnostic criteria for FAS
or PFAS or were exposed to alcohol no more than minimal
during pregnancy (controls) were included in the study.
A total of 24 FAS/PFAS children and 20 control non-
exposed right-handed children participated including nine of
children with FAS/PFAS and seven of the control children
that also participated in the visual study [3]. However, ERP
from 12 of the children with FAS/PFAS and 9 of the normal
control children were not available for analysis due to technical
difficulties, poorly formed ERP, inability to perform the task, or
uncooperative behavior of the child. The remaining 12 children
with FAS/PFAS and 11 normal controls were included in the
analyses. To asses the participants perceptual hearing threshold
of the participants an audiology screening was conducted prior
to the auditory Go/No-Go task.
B. Go/No-Go Task
In the auditory Go/No-Go task the child was instructed
to press a button with the right index finger as soon as
possible in response to every 1000Hz tone (Go trials) and
not to press the button when the 2000Hz tone was heard (No-
Go trial). The auditory stimuli had a duration of 500ms and
were presented with an inter-stimulus-interval of 4500ms with
silence in between. Go and No-Go stimuli were presented
randomly within 7 consecutive blocks of 50 trials each (35 Go
and 15 No-Go) resulting in a total of 350 trials. Each block
was preceded by a 1 minute rest period.
C. Electroencephalography Recording
Continuous eletroencephalography (EEG) data were recorded
using a 128-channel Electro Geodesics (EGI) Net Amps 200
system with a HydroCel Geodesic Sensor Net (HCGSN). The
EEG signals were digitized at a rate of 250Hz. In this study
only electrodes matching those of the international 10-20 was
considered, that is anterior-frontal (Fp1, Fp2), frontal (F3,
F4, F7, F8, Fz), central (C3, C4), parietal (P3, P4, Pz), and
occipital (O1, O2, Oz). In addition left and right mastoids (LM,
RM), bipolar electrodes placed at the canthi of the right eye,
and bipolar electrodes placed above and below the eye were
recorded for re-referencing and artifact detection and correction.
All electrodes were recorded with Cz as reference.
D. ERP Data Analysis
ERPs were derived offline using routines developed in
MATLAB 2010A (MathWorks, USA). All trials were re-
referenced to average mastoids and electrooculogram (EOG)
corrected using the eye movement correction procedure (EMCP)
described in [10] prior to averaging. In the EMCP the event
related eye movement is estimated and subtracted from the
EOG channel before using it for correcting the EEG data. For
correcting the EEG data a correction factor K is calculated by
solving K, using linear regression model with least squares
estimator, in the equation,
Vt −Vt = K(EOGt −EOGt) (1)
Here Vt is the EEG potential at time point t, Vt is the ERP
potential (average of stimuli time locked EEG trials), EOGt is
the raw EOG channel data at time point t, and EOGt is the
averaged trial EOG derived by time locking the EOG for each
trial to the eliciting event (Go/No-Go stimuli). All validated
(cf. next paragraph) trial data is used in the regression. The
corrected EEG is calculated using,
Corrected EEG= RawEEG−K(RawEOG) (2)
The EOG channel data was digitally bandpass filtered with
lower and higher cutoff frequencies of 0.53Hz and 13Hz before
being used in the EMCP.
Prior to EOG correction the EEG data were digitally
bandpass filtered with lower and higher cutoff frequencies of
0.796Hz and 30Hz. Trials with channels exceeding ±150µV
or with extreme wave morphology were rejected as well as trials
with incorrect responses (button press after No-Go stimulus
or lacking button press after Go stimulus). For the EOG
channel trials exceeding ±1000µV were rejected. Individual
ERP averages of the remaining EOG-corrected trials were
computed with segments consisting of a baseline period of
100ms prior to stimulus onset followed by a 1500ms post
stimulus recording. Peak detection was used to identify the
amplitude and latency of the following three ERP components:
P2, a positive deflection in the interval 100ms to 280ms
from stimulus onset; N2, a negative deflection in the interval
200ms to 360ms; and P3, a positive deflection in the interval
280ms to 600ms. The intervals were chosen in collaboration
with a board certified clinical neurophysiologist Troels W. Kjær
(TWK) such that the components in the individual subject ERPs
would all be detected. The amplitude measures reported for
these components represent mean activity surrounding the peak
(±20ms).
E. Statistical Analysis
Mixed design repeated measures analyses of variance
(ANOVA) was used to assess behavioral task performance
for correct responses and mean reaction time (RT) in separate
2 (group: FAS/PFAS, controls) × 2 (condition: Go, No-Go)
analyses, with group as between-subject factor and condition
as the within-subjects factor. For ERPs, repeated measures
ANOVAs were used to measure peak amplitude (µV) and
latency (ms) effects for P2, N2, and P3, focusing on the 6
electrodes where effects were maximal (F3, Fz, F4, C3, Cz, C4)
in a 2×2×3×2 (group; condition; hemisphere: left, midline,
right; region: frontal, central) design, with group as the between-
subjects factor. All statistical analyses were conducted using
MATLAB 2010A Statistics Toolbox.
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Table I
DEMOGRAPHIC CHARACTERISTICS BY EXPOSURE GROUPS
FAS/PFAS (n= 12) Controls (n= 11)
M (SD) or n (%) Range M (SD) or n (%) Range F
Child characteristics
Gender (number of females) 8 (66.7) — 4 (36.4) —
Age at test (years) 13.0 (1.13) 11.3−14.6 12.8 (1.3) 11.0−14.7 < 1
Lead (Pb; µg/dl) 5.0 (2.4) 2−12 7.1 (3.3) 3−12 1.80
Maternal characteristics
Age at delivery (years) 25.2 (5.5) 17.2−33.1 26.7 (6.2) 14.9−40.1 < 1
Socioeconomic status 17.4 (6.6) 9.5−29 19.3 (10.0) 6−37.5 < 1
Education (years) 7.45 (3.0) 0−10 8.2 (1.8) 6−12 < 1
Marital status (number married) 5 (42.0) — 6 (54.5) —
Cigarettes during pregnancy (per day) 11.0 (8.8) 0−30 9.8 (7.0) 0−20 < 1
Table II
MEANS (STANDARD DEVIATIONS) FOR BEHAVIORAL PERFORMANCE
FAS/PFAS (n= 12) Controls (n= 11)
Accuracy
Correct Go (%) 95.9 (5.5) 96.4 (6.7)
Correct No-Go (%) 85.1 (11.5) 85.8 (9.1)
Reaction time
Correct Go (ms) 634 (624;643) 613 (602;625)
III. RESULTS
A. Background Characteristics
In Table I the demographic characteristics of child and the
primary caregiver. The FAS/PFAS group and the controls group
did differ in case of the gender and the lead levels. None
of the mothers reported use of cocaine, marijuana, hashish,
methaqualone (“mandrax”), or other drugs during pregnancy,
and no significant (α = 0.01) group differences were found in
number of cigarettes smoked per day.
B. Behavioral Performance
For the sample as a whole, there was a greater accuracy
(% correct) for Go versus No-Go trials, M = 96.1% (Go) vs.
M = 85.4% (No Go), t = 38.5, p< 0.05. This indicates that it
is more difficult to inhibit a response than to execute the button
press, as expected [3]. There was no significant difference in
Go reaction time between the groups (t = −2.65, p < 0.05).
The overall performance was high as seen in Table II.
C. ERP Measures
In Figure 1 the grand ensemble ERPs for the two groups
and the two conditions are shown. In Table III the latencies
and amplitudes calculated using a full automatic system for
the regions where the effects were identified as maximal.
The P2 amplitude showed a condition effect, F1,21 = 5.88,
p= 0.02, indicating an overall larger P2 to Go vs. No-Go. A
hemisphere×region interaction was also found, F2,42 = 16.94,
p< 0.05, and follow-up test indicated that there was an overall
difference between midline-frontal and midline central, M =
4.36µV vs. M = 8.67µV, F1,90 = 27.75, p< 0.05. An central
hemisphere effect was also evident with highest amplitudes at
the midline (M = 8.6µV) compared to left (M = 5.0µV) and
























Figure 1. Stimulus-locked grand means at Fz, Cz* (Cz was used as reference,
E55 shown here) for controls Go (thin gray), controls No-Go (bold gray),
FAS/PFAS go (thin black), and FAS/PFAS No-Go (bold black). Baseline period
(100ms) represents 100ms prior to stimulus onset.
Table III
ERP COMPONENT MEANS AND STANDARD ERRORS. AMPLITUDES FROM FZ
AND LATENCIES FROM C3.
FAS (n= 12) Controls (n= 11)
Go No Go Go No Go
P2
Latency (ms) 209 (11.9) 209 (10.8) 205 (19.9) 215 (24.5)
Amplitude (µV) 4.9 (4.3) 2.8 (4.4) 5 (3.5) 4.9 (3.9)
N2
Latency (ms) 290 (28.9) 260 (24) 276 (31.6) 277 (20.3)
Amplitude (µV) -3.5 (2.6) -4.1 (2.7) -3.6 (3) -4.2 (3.2)
P3
Latency (ms) 338 (27.2) 318 (16.4) 333 (33.6) 330 (25.9)
Amplitude (µV) 2 (2.1) 4.2 (3.6) 1.8 (2.9) 2.6 (3.3)
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For P2 latencies there was a main effect for for hemisphere,
F2,21 = 4.10, p = 0.027, indicating that the latencies were
slower for the left hemisphere (M = 206.7ms) compared to
midline (M = 200.9ms).
The N2 amplitudes had a significant hemisphere × region
interaction, F2,42 = 7.93, p= 0.017. Post hoc tests revealed that
there were greater N2 (more negative) in the frontal sites versus
the central sites for left and right hemispheres. In the central
region there was a more negative N2 at the right hemisphere
versus the midline.
For N2 latency there was a group × condition interaction
effect. A significant difference between the two groups for
the Go trials was found, F1,136 = 6.25, p= 0.0136, Mcontrol =
270ms vs MFASD = 281ms. Furthermore a difference between
Go and No-Go trials in the FAS/PFAS group was evident,
F1,142 = 19.41, p < 0.005, MFASD,go = 281ms vs MFASD,ng =
263ms, an effect completely absent in the normal control group.
For the P3 amplitude there was a main condition effect,
F1,21 = 9.79, p= 0.005, indicating higher P3 amplitude to No-
Go vs Go. A main region effect, F1,21 = 7.03, p< 0.05, was
also found, which indicated a higher overall P3 amplitude for
the frontal vs central sites, M = 2.78µV vs M = 1.87µV. For
the P3 latency there was an overall region effect, F1,21 = 7.18,
p= 0.014, that indicated slower latencies at the frontal sites.
IV. DISCUSSION
This study is one of few to identify deficits in response
inhibition in children with FAS/PFAS using ERPs. Both the
normal controls and the FAS/PFAS groups performed well
in the Go/No Go task which was expected as the task was
designed to be relatively easy to minimize group differences.
As expected the subjects made more errors in the No Go trials
than in the Go trials [3], [11].
However several effects became clear in the ERP analyses.
P2, which is thought to play a role in early stimulus clas-
sification and possible response inhibition, showed a larger
amplitude in response to Go vs. No-Go in both groups, which
could signify an early discrimination of the stimulus. In [3]
this effect was only seen in the normal controls, however this
difference could originate from the different stimulus paradigm
(auditory vs. visual).
On N2 the longer latencies to Go trials in the FAS/PFAS
was unexpected. Davis et al. [11] contrarily found a shorter
N2 latency for children (6years to 7years) in response to Go
compared to No Go. However, for adults Davis et al. found
the opposite which could indicate that different processes is
being used at different ages. The children in the control group
did not show any differences in Go vs No-Go. These results
may indicate that at this age (13years) the latencies start to
shift. The lack of amplitude differences in relation to condition
was unexpected as this is normally a clear marker for response
inhibition.
Both groups showed as expected a larger P3 to No-Go,
which likely indicates an increased allocation of attention when
actively inhibiting a prepotent tendency to respond. This link
between the P3 amplitude and response inhibition has been
documented repeatedly in the literature [12], [5], [3].
In summary this study has indicated several ERPs results
in response to auditory stimuli similarly to those found by
Burden et al. 2009 [3] and added to the knowledge about the
specific changes in ERP caused by FASD.
V. FUTURE WORK
Inclusion of gender in the analysis. Investigation of more
advanced peak detection methods and use of advanced track-
ing methods such as the Kalman filtering used in [13]
could improve time series analyses like those done in this
study. Furthermore it could be interesting to investigate the
time–frequency structure of ERPs of patients with FASD.
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